메뉴 건너뛰기




Volumn 14, Issue 2, 2012, Pages 175-182

Telecare provides comparable efficacy to conventional self-monitored blood glucose in patients with type 2 diabetes titrating one injection of insulin glulisine-the ELEONOR study

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; GLUCOSE; HEMOGLOBIN A1C; INSULIN GLARGINE; INSULIN GLULISINE; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA DERIVATIVE;

EID: 84855848753     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2011.0163     Document Type: Article
Times cited : (43)

References (22)
  • 1
    • 0036291924 scopus 로고    scopus 로고
    • Are there time and cost savings by using telemanagement for patients on intensified insulin therapy?: A randomised, controlled trial
    • DOI 10.1016/S0169-2607(02)00037-8, PII S0169260702000378
    • Biermann E, Dietrich W, Rihl J, Standl E: Are there time and cost savings by using telemanagement for patients on intensified insulin therapy? A randomised, controlled trial. Comput Methods Programs Biomed 2002;69:137-146. (Pubitemid 34722935)
    • (2002) Computer Methods and Programs in Biomedicine , vol.69 , Issue.2 , pp. 137-146
    • Biermann, E.1    Dietrich, W.2    Rihl, J.3    Standl, E.4
  • 3
    • 2342506512 scopus 로고    scopus 로고
    • Telecare for Patients with Type 1 Diabetes and Inadequate Glycemic Control: A randomized controlled trial and meta-analysis
    • DOI 10.2337/diacare.27.5.1088
    • Montori VM, Helgemoe PK, Guyatt GH, Dean DS, Leung TW, Smith SA, Kudva YC: Telecare for patients with type 1 diabetes and inadequate glycemic control: a randomized controlled trial and meta-analysis. Diabetes Care 2004;27: 1088-1094. (Pubitemid 38579771)
    • (2004) Diabetes Care , vol.27 , Issue.5 , pp. 1088-1094
    • Montori, V.M.1    Helgemoe, P.K.2    Guyatt, G.H.3    Dean, D.S.4    Leung, T.W.5    Smith, S.A.6    Kudva, Y.C.7
  • 4
    • 34548423735 scopus 로고    scopus 로고
    • New technologies for chronic disease management and control: A systematic review
    • Garcia-Lizana F, Sarria-Santamera A: New technologies for chronic disease management and control: a systematic review. J Telemed Telecare 2007;13:62-68.
    • (2007) J Telemed Telecare , vol.13 , pp. 62-68
    • Garcia-Lizana, F.1    Sarria-Santamera, A.2
  • 5
    • 60449089649 scopus 로고    scopus 로고
    • Medical management of hyper-glycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
    • Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B: Medical management of hyper-glycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009; 32:193-203.
    • (2009) Diabetes Care , vol.32 , pp. 193-203
    • Nathan, D.M.1    Buse, J.B.2    Davidson, M.B.3    Ferrannini, E.4    Holman, R.R.5    Sherwin, R.6    Zinman, B.7
  • 7
    • 61549116581 scopus 로고    scopus 로고
    • Insulin glargine provides greater improvements in glycaemic control vs. intensifying lifestyle management for people with type 2 diabetes treated with OADs and 7-8% A1c levels. The TULIP study
    • Blickle JF, Hancu N, Piletic M, Profozic V, Shestakova M, Dain MP, Jacqueminet S, Grimaldi A: Insulin glargine provides greater improvements in glycaemic control vs. intensifying lifestyle management for people with type 2 diabetes treated with OADs and 7-8% A1c levels. The TULIP study. Diabetes Obes Metab 2009;11:379-386.
    • (2009) Diabetes Obes Metab , vol.11 , pp. 379-386
    • Blickle, J.F.1    Hancu, N.2    Piletic, M.3    Profozic, V.4    Shestakova, M.5    Dain, M.P.6    Jacqueminet, S.7    Grimaldi, A.8
  • 8
    • 12844276465 scopus 로고    scopus 로고
    • Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes
    • DOI 10.2337/diacare.28.2.254
    • Janka HU, Plewe G, Riddle MC, Kliebe-Frisch C, Schweitzer MA, Yki-Jarvinen H: Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes. Diabetes Care 2005;28: 254-259. (Pubitemid 40170922)
    • (2005) Diabetes Care , vol.28 , Issue.2 , pp. 254-259
    • Janka, H.U.1    Plewe, G.2    Riddle, M.C.3    Kliebe-Frisch, C.4    Schweitzer, M.A.5    Yki-Jarvinen, H.6
  • 9
    • 55449131463 scopus 로고    scopus 로고
    • Introducing a simplified approach to insulin therapy in type 2 diabetes: A comparison of two single-dose regimens of insulin glulisine plus insulin glargine and oral antidiabetic drugs
    • Lankisch MR, Ferlinz KC, Leahy JL, Scherbaum WA: Introducing a simplified approach to insulin therapy in type 2 diabetes: a comparison of two single-dose regimens of insulin glulisine plus insulin glargine and oral antidiabetic drugs. Diabetes Obes Metab 2008;10:1178-1185.
    • (2008) Diabetes Obes Metab , vol.10 , pp. 1178-1185
    • Lankisch, M.R.1    Ferlinz, K.C.2    Leahy, J.L.3    Scherbaum, W.A.4
  • 10
    • 63449117033 scopus 로고    scopus 로고
    • Options for the intensification of insulin therapy when basal insulin is not enough in type 2 diabetes mellitus
    • Raccah D: Options for the intensification of insulin therapy when basal insulin is not enough in type 2 diabetes mellitus. Diabetes Obes Metab 2008;10(Suppl 2):76-82.
    • (2008) Diabetes Obes Metab , vol.10 , Issue.SUPPL. 2 , pp. 76-82
    • Raccah, D.1
  • 11
    • 34249807045 scopus 로고    scopus 로고
    • When basal insulin therapy in type 2 diabetes mellitus is not enough - What next?
    • DOI 10.1002/dmrr.733
    • Raccah D, Bretzel RG, Owens D, Riddle M: When basal insulin therapy in type 2 diabetes mellitus is not enough- what next? Diabetes Metab Res Rev 2007;23:257-264. (Pubitemid 46851465)
    • (2007) Diabetes/Metabolism Research and Reviews , vol.23 , Issue.4 , pp. 257-264
    • Raccah, D.1    Bretzel, R.G.2    Owens, D.3    Ridlle, M.4
  • 12
    • 80053385824 scopus 로고    scopus 로고
    • Effects of initiation and titration of a single pre-prandial dose of insulin glulisine while continuing titrated insulin glargine in type 2 diabetes: A 6-month 'proof-of-concept' study
    • Owens DR, Luzio SD, Sert-Langeron C, Riddle MC: Effects of initiation and titration of a single pre-prandial dose of insulin glulisine while continuing titrated insulin glargine in type 2 diabetes: a 6-month 'proof-of-concept' study. Diabetes Obes Metab 2011;13:1020-1027.
    • (2011) Diabetes Obes Metab , vol.13 , pp. 1020-1027
    • Owens, D.R.1    Luzio, S.D.2    Sert-Langeron, C.3    Riddle, M.C.4
  • 13
    • 43049106459 scopus 로고    scopus 로고
    • Effectiveness of mobile and internet intervention in patients with obese type 2 diabetes
    • Kim SI, Kim HS: Effectiveness of mobile and internet intervention in patients with obese type 2 diabetes. Int J Med Inform 2008;77:399-404.
    • (2008) Int J Med Inform , vol.77 , pp. 399-404
    • Kim, S.I.1    Kim, H.S.2
  • 14
    • 65649135889 scopus 로고    scopus 로고
    • Mobile communication using a mobile phone with a glucometer for glucose control in Type 2 patients with diabetes: As effective as an Internet-based glucose monitoring system
    • Cho JH, Lee HC, Lim DJ, Kwon HS, Yoon KH: Mobile communication using a mobile phone with a glucometer for glucose control in Type 2 patients with diabetes: as effective as an Internet-based glucose monitoring system. J Telemed Telecare 2009;15:77-82.
    • (2009) J Telemed Telecare , vol.15 , pp. 77-82
    • Cho, J.H.1    Lee, H.C.2    Lim, D.J.3    Kwon, H.S.4    Yoon, K.H.5
  • 16
    • 0242269000 scopus 로고    scopus 로고
    • The Treat-to-Target Trial: Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients
    • DOI 10.2337/diacare.26.11.3080
    • Riddle MC, Rosenstock J, Gerich J: The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care 2003;26:3080-3086. (Pubitemid 37339502)
    • (2003) Diabetes Care , vol.26 , Issue.11 , pp. 3080-3086
    • Riddle, M.C.1    Rosenstock, J.2    Gerich, J.3
  • 17
    • 84855858598 scopus 로고    scopus 로고
    • Optimizing insulin glargine plus one injection of insulin glulisine in type 2 diabetes in the ELEONOR Study: Similar effects of telecare and conventional self monitoring of blood glucose on patient functional health status and treatment satisfaction
    • Nicolucci A, Del Prato S, Vespasianni G; ELEONOR Study Group: Optimizing insulin glargine plus one injection of insulin glulisine in type 2 diabetes in the ELEONOR Study: similar effects of telecare and conventional self monitoring of blood glucose on patient functional health status and treatment satisfaction. Diabetes Care 2011;34: 2524-2526.
    • (2011) Diabetes Care , vol.34 , pp. 2524-2526
    • Nicolucci, A.1    Del Prato, S.2    Vespasianni, G.3
  • 18
    • 49649123535 scopus 로고    scopus 로고
    • Adjust to target in type 2 diabetes: Comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine
    • Bergenstal RM, Johnson M, Powers MA, Wynne A, Vlajnic A, Hollander P, Rendell M: Adjust to target in type 2 diabetes: comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine. Diabetes Care 2008;31:1305-1310.
    • (2008) Diabetes Care , vol.31 , pp. 1305-1310
    • Bergenstal, R.M.1    Johnson, M.2    Powers, M.A.3    Wynne, A.4    Vlajnic, A.5    Hollander, P.6    Rendell, M.7
  • 19
    • 6944244979 scopus 로고    scopus 로고
    • Insulin detemir and insulin aspart: A promising basal-bolus regimen for type 2 diabetes
    • DOI 10.1016/j.diabres.2004.03.003, PII S0168822704000695
    • Raslova K, Bogoev M, Raz I, Leth G, Gall MA, Hancu N: Insulin detemir and insulin aspart: a promising basal-bolus regimen for type 2 diabetes. Diabetes Res Clin Pract 2004;66:193-201. (Pubitemid 39469347)
    • (2004) Diabetes Research and Clinical Practice , vol.66 , Issue.2 , pp. 193-201
    • Raslova, K.1    Bogoev, M.2    Raz, I.3    Leth, G.4    Gall, M.-A.5    Hancu, N.6
  • 20
    • 57649230070 scopus 로고    scopus 로고
    • A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes
    • Hollander P, Cooper J, Bregnhoj J, Pedersen CB: A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes. Clin Ther 2008;30: 1976-1987.
    • (2008) Clin Ther , vol.30 , pp. 1976-1987
    • Hollander, P.1    Cooper, J.2    Bregnhoj, J.3    Pedersen, C.B.4
  • 21
    • 70350605350 scopus 로고    scopus 로고
    • Comparison of insulin detemir and insulin glargine using a basal-bolus regimen in a randomized, controlled clinical study in patients with type 2 diabetes
    • Raskin P, Gylvin T, Weng W, Chaykin L: Comparison of insulin detemir and insulin glargine using a basal-bolus regimen in a randomized, controlled clinical study in patients with type 2 diabetes. Diabetes Metab Res Rev 2009; 25:542-548.
    • (2009) Diabetes Metab Res Rev , vol.25 , pp. 542-548
    • Raskin, P.1    Gylvin, T.2    Weng, W.3    Chaykin, L.4
  • 22
    • 78649713954 scopus 로고    scopus 로고
    • Weight neutrality with the DPP-4 inhibitor, vildagliptin: Mechanistic basis and clinical experience
    • Foley JE, Jordan J: Weight neutrality with the DPP-4 inhibitor, vildagliptin: mechanistic basis and clinical experience. Vasc Health Risk Manag 2010;6:541-548.
    • (2010) Vasc Health Risk Manag , vol.6 , pp. 541-548
    • Foley, J.E.1    Jordan, J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.